vs
Simulations Plus, Inc.（SLP）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
Simulations Plus, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.4倍（$18.4M vs $13.2M），Simulations Plus, Inc.净利率更高（3.7% vs -73.9%，领先77.5%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs -2.7%），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 0.3%）
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
SLP vs TLSI — 直观对比
营收规模更大
SLP
是对方的1.4倍
$13.2M
营收增速更快
TLSI
高出62.5%
-2.7%
净利率更高
SLP
高出77.5%
-73.9%
两年增速更快
TLSI
近两年复合增速
0.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.4M | $13.2M |
| 净利润 | $676.0K | $-9.8M |
| 毛利率 | 59.1% | 86.7% |
| 营业利润率 | 3.9% | -24.8% |
| 净利率 | 3.7% | -73.9% |
| 营收同比 | -2.7% | 59.8% |
| 净利润同比 | 228.2% | 3.5% |
| 每股收益（稀释后） | $0.03 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLPTLSI
| Q4 25 | $18.4M | $13.2M | ||
| Q3 25 | $17.5M | $11.6M | ||
| Q2 25 | $20.4M | $11.2M | ||
| Q1 25 | $22.4M | $9.2M | ||
| Q4 24 | $18.9M | $8.3M | ||
| Q3 24 | $18.7M | $7.3M | ||
| Q2 24 | $18.5M | $7.4M | ||
| Q1 24 | $18.3M | $6.5M |
净利润SLPTLSI
| Q4 25 | $676.0K | $-9.8M | ||
| Q3 25 | $-681.0K | $-10.8M | ||
| Q2 25 | $-67.3M | $-8.3M | ||
| Q1 25 | $3.1M | $-10.4M | ||
| Q4 24 | $206.0K | $-10.1M | ||
| Q3 24 | $843.0K | $-2.4M | ||
| Q2 24 | $3.1M | $-4.3M | ||
| Q1 24 | $4.0M | $-13.2M |
毛利率SLPTLSI
| Q4 25 | 59.1% | 86.7% | ||
| Q3 25 | 56.4% | 83.5% | ||
| Q2 25 | 64.0% | 83.9% | ||
| Q1 25 | 58.5% | 83.7% | ||
| Q4 24 | 54.0% | 85.3% | ||
| Q3 24 | 36.6% | 86.3% | ||
| Q2 24 | 71.5% | 87.6% | ||
| Q1 24 | 72.2% | 85.0% |
营业利润率SLPTLSI
| Q4 25 | 3.9% | -24.8% | ||
| Q3 25 | 3.8% | -77.9% | ||
| Q2 25 | -364.5% | -65.4% | ||
| Q1 25 | 12.1% | -79.9% | ||
| Q4 24 | 0.7% | -91.8% | ||
| Q3 24 | -6.2% | -118.9% | ||
| Q2 24 | 10.1% | -111.0% | ||
| Q1 24 | 24.3% | -180.8% |
净利率SLPTLSI
| Q4 25 | 3.7% | -73.9% | ||
| Q3 25 | -3.9% | -93.5% | ||
| Q2 25 | -330.6% | -73.9% | ||
| Q1 25 | 13.7% | -113.2% | ||
| Q4 24 | 1.1% | -122.4% | ||
| Q3 24 | 4.5% | -32.6% | ||
| Q2 24 | 16.9% | -58.8% | ||
| Q1 24 | 22.0% | -204.5% |
每股收益（稀释后）SLPTLSI
| Q4 25 | $0.03 | $-0.22 | ||
| Q3 25 | $-0.03 | $-0.96 | ||
| Q2 25 | $-3.35 | $-0.27 | ||
| Q1 25 | $0.15 | $-0.39 | ||
| Q4 24 | $0.01 | $-0.38 | ||
| Q3 24 | $0.04 | $-0.12 | ||
| Q2 24 | $0.15 | $-0.21 | ||
| Q1 24 | $0.20 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.7M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $127.1M | $-33.9M |
| 总资产 | $137.8M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SLPTLSI
| Q4 25 | $35.7M | $20.4M | ||
| Q3 25 | $32.4M | $22.7M | ||
| Q2 25 | $28.4M | $26.5M | ||
| Q1 25 | $21.4M | $13.0M | ||
| Q4 24 | $18.2M | $8.5M | ||
| Q3 24 | $20.3M | $11.3M | ||
| Q2 24 | $119.0M | $16.5M | ||
| Q1 24 | $108.5M | $4.0M |
股东权益SLPTLSI
| Q4 25 | $127.1M | $-33.9M | ||
| Q3 25 | $124.8M | $-26.7M | ||
| Q2 25 | $123.8M | $-19.4M | ||
| Q1 25 | $189.5M | $-34.4M | ||
| Q4 24 | $184.7M | $-25.9M | ||
| Q3 24 | $182.4M | $-20.4M | ||
| Q2 24 | $180.9M | $-25.3M | ||
| Q1 24 | $177.0M | $-36.0M |
总资产SLPTLSI
| Q4 25 | $137.8M | $35.3M | ||
| Q3 25 | $131.9M | $36.5M | ||
| Q2 25 | $134.4M | $41.3M | ||
| Q1 25 | $201.4M | $28.6M | ||
| Q4 24 | $196.9M | $24.0M | ||
| Q3 24 | $196.6M | $27.5M | ||
| Q2 24 | $192.7M | $32.4M | ||
| Q1 24 | $194.0M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.2M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | 6.26× | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流SLPTLSI
| Q4 25 | $4.2M | $-2.5M | ||
| Q3 25 | $5.6M | $-3.7M | ||
| Q2 25 | $8.1M | $-7.3M | ||
| Q1 25 | $5.7M | $-4.5M | ||
| Q4 24 | $-1.3M | $-5.7M | ||
| Q3 24 | $1.7M | $-10.8M | ||
| Q2 24 | $5.7M | $-13.4M | ||
| Q1 24 | $5.8M | $-10.9M |
自由现金流SLPTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $5.3M | $-3.9M | ||
| Q2 25 | $7.8M | $-7.4M | ||
| Q1 25 | $5.6M | $-5.3M | ||
| Q4 24 | $-1.4M | $-5.8M | ||
| Q3 24 | $1.6M | $-11.0M | ||
| Q2 24 | $5.6M | $-13.5M | ||
| Q1 24 | $5.4M | $-10.9M |
自由现金流率SLPTLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | 30.5% | -33.9% | ||
| Q2 25 | 38.5% | -66.1% | ||
| Q1 25 | 25.0% | -57.3% | ||
| Q4 24 | -7.2% | -69.7% | ||
| Q3 24 | 8.8% | -149.9% | ||
| Q2 24 | 30.0% | -183.1% | ||
| Q1 24 | 29.4% | -169.3% |
资本支出强度SLPTLSI
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 1.5% | 1.9% | ||
| Q2 25 | 1.5% | 0.8% | ||
| Q1 25 | 0.3% | 8.2% | ||
| Q4 24 | 0.5% | 0.6% | ||
| Q3 24 | 0.1% | 2.3% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 2.4% | 1.0% |
现金转化率SLPTLSI
| Q4 25 | 6.26× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | -6.18× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 1.81× | — | ||
| Q1 24 | 1.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
TLSI
暂无分部数据
